Microfluidic Cell Lamp Component Distribution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Microfluidic medical test devices face challenges in preserving reactive substances and buffers during storage and transportation, with existing methods being unpredictable and prone to experimental errors, especially when used for diagnosing sexually transmitted diseases like Chlamydia using LAMP amplification.
Innovation Solution
A microfluidic test device design where the primary reaction material and the first buffer are arranged on different sides of the sample inlet, with the primary reaction material in a lyophilized form, allowing for easier production and storage at room temperature without adverse effects, enabling point-of-care detection of sexually transmitted diseases with high sensitivity and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If reactive substances and buffers are stored together in microfluidic devices, then the device is ready for immediate use, but the substances degrade during storage and transportation
Solution Approach 1:
The device separates reactive substances and buffers into different chambers or compartments within the microfluidic structure. This physical segmentation prevents unwanted interactions during storage while allowing controlled mixing during operation, thus maintaining substance stability during storage while ensuring immediate use readiness when needed.
Solution Approach 2:
The microfluidic device is pre-assembled with all necessary components, chambers, and fluid paths in place before use. The reactive substances and buffers are pre-positioned in their respective compartments in a stable state. When activation occurs, the pre-configured system immediately begins operation without requiring additional assembly or preparation steps.
2Reliability
If lyophilization is used to preserve reactive substances, then storage stability is improved, but the production process becomes unpredictable and prone to errors
Solution Approach 1:
The device separates lyophilized reactive substances from liquid buffers into different chambers. This segmentation allows the reactive substances to be stored in a stable lyophilized state while the buffers remain in liquid form, avoiding the unpredictable aspects of lyophilizing buffers while maintaining storage stability for the reactive components.
Solution Approach 2:
The microfluidic device structure itself acts as an intermediary that protects and stabilizes the lyophilized substances during storage and manufacturing. The controlled environment of the sealed microfluidic chambers provides a protective matrix that reduces variability in the lyophilization process and ensures consistent results.
3Ease of operation
If room temperature storage is implemented, then convenience of storage and transport is improved, but substance degradation occurs
Solution Approach 1:
The device segments reactive substances and buffers into separate compartments that can be stored at room temperature. This physical separation prevents degradation reactions that would occur if the substances were mixed, allowing convenient room temperature storage and transport while maintaining substance stability through the protective isolation provided by the microfluidic chamber structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device allows for rapid detection of sexually transmitted diseases like Chlamydia in under an hour with sensitivity higher than 70% and specificity near 100%, while maintaining the stability and convenience of long-term storage and transport.
Implementation Method 1
the primary reaction material in a lyophilized form
Data Source
AI summary
A microfluidic test device has a body, a first chamber having an outlet provided with a first valve and holding a first buffer having a first buffer volume, a primary reaction chamber, a sample inlet for receiving and feeding a sample having a sample volume, into the microfluidic test device, a first fluid path connecting the outlet of the first chamber and the sample inlet, a second fluid path connecting the sample inlet and the primary reaction chamber, a primary test part having a primary test chamber, a third primary fluid path connecting the primary reaction chamber and the primary test part, a primary valve arranged in the third primary fluid path, a flow driving device configured to move fluid from the primary reaction chamber to the primary test part, and a heating assembly configured to heat a reaction fluid in the primary reaction chamber.